Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
CALL
Mettler-Toledo International
MTD
$28B
| $3.93M | ﹤0.01% |
3,000
+2,000
| +200% | +$2.81M |
|
|
2827
PUT
Mettler-Toledo International
MTD
$28B
| $3.93M | ﹤0.01% |
+3,000
| New | +$4.22M |
|
|
NOTV
2828
DELISTED
Inotiv
NOTV
| $3.93M | ﹤0.01% |
824,148
+738,054
| +857% | +$4.08M |
|
2829
Columbia Sportswear
COLM
$2.97B
| $3.92M | ﹤0.01% |
50,812
+21,964
| +76% | +$1.77M |
|
2830
Arbutus Biopharma
ABUS
$1B
| $3.92M | ﹤0.01% |
1,702,182
+41,616
| +3% | +$108K |
|
2831
PUT
Abercrombie & Fitch
ANF
$6.59B
| $3.91M | ﹤0.01% |
+103,800
| New | +$2.96M |
|
2832
Vanguard Total International Bond ETF
BNDX
$82.5B
| $3.91M | ﹤0.01% |
79,966
+49,180
| +160% | +$2.4M |
|
2833
Grand Canyon Education
LOPE
$3.94B
| $3.91M | ﹤0.01% |
37,853
+25,609
| +209% | +$2.81M |
|
2834
CALL
Immunocore
IMCR
$1.89B
| $3.9M | ﹤0.01% |
65,000
| – | – |
|
2835
Oaktree Specialty Lending
OCSL
$1.15B
| $3.9M | ﹤0.01% |
200,540
-308,008
| -61% | -$5.79M |
|
|
HEES
2836
DELISTED
H&E Equipment Services
HEES
| $3.89M | ﹤0.01% |
85,081
+50,011
| +143% | +$2M |
|
2837
Sabesp
SBS
$17.1B
| $3.89M | ﹤0.01% |
1,693,809
-3,333,496
| -66% | -$6.68M |
|
2838
Rapid7
RPD
$896M
| $3.89M | ﹤0.01% |
85,839
-424,926
| -83% | -$19.7M |
|
2839
PUT
Rio Tinto
RIO
$168B
| $3.88M | ﹤0.01% |
60,700
+35,700
| +143% | +$2.3M |
|
2840
CALL
Baxter International
BAX
$13.5B
| $3.87M | ﹤0.01% |
+85,000
| New | +$3.7M |
|
2841
CALL
Hewlett Packard
HPE
$69.3B
| $3.87M | ﹤0.01% |
230,300
+208,300
| +947% | +$3.19M |
|
2842
Gerdau
GGB
$9.01B
| $3.86M | ﹤0.01% |
887,917
-3,157,663
| -78% | -$13.2M |
|
2843
RLX Technology
RLX
$2.24B
| $3.85M | ﹤0.01% |
2,177,355
-3,986,938
| -65% | -$8.92M |
|
|
FSP
2844
Franklin Street Properties
FSP
$42.2M
| $3.85M | ﹤0.01% |
2,654,875
+573,617
| +28% | +$794K |
|
2845
Genworth Financial
GNW
$3.77B
| $3.84M | ﹤0.01% |
768,146
-526,025
| -41% | -$2.88M |
|
2846
CALL
Five Below
FIVE
$13.4B
| $3.83M | ﹤0.01% |
+19,500
| New | +$3.81M |
|
|
ZPTA
2847
DELISTED
Zapata Computing Holdings Inc. Common Stock
ZPTA
| $3.83M | ﹤0.01% |
360,000
| – | – |
|
2848
Pebblebrook Hotel Trust
PEB
$2.09B
| $3.83M | ﹤0.01% |
274,654
+258,261
| +1,575% | +$3.6M |
|
|
PYCR
2849
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $3.83M | ﹤0.01% |
161,746
-241,809
| -60% | -$5.64M |
|
2850
Vanda Pharmaceuticals
VNDA
$320M
| $3.82M | ﹤0.01% |
579,774
-1,181,954
| -67% | -$7.58M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.